Background illustration for clinical trials search

Paid Clinical Trials Edmond

Discover 573 paid clinical trials in Edmond, Oklahoma. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.

Filter
2

GEMINI-NSCLC: NSCLC Biomarker Study

for
Non-Small Cell Lung Cancer
Location: Oklahoma City OK, Tulsa OK, Fort Smith AR, Joplin MO,
Sponsor: Tempus AI

Sex: All

Age: 18+

Code: NCT05236114

Recruiting

A Study to Evaluate the Effectiveness and Safety of Setidegrasib, Given With Either mFOLFIRINOX or NALIRIFOX Chemotherapies, in People With Pancreatic Cancer

for
Pancreatic Cancer, Metastatic Pancreatic Cancer,
Location: Oklahoma City OK, Fort Smith AR, Dallas TX,
Sponsor: Astellas Pharma Global Development, Inc.

Sex: All

Age: 18+

Code: NCT07409272

Phase 3, Recruiting

Melanoma Margins Trial-II: 1cm v 2cm Wide Surgical Excision Margins for AJCC Stage II Primary Cutaneous Melanoma

for
Cutaneous Melanoma, Stage II
Location: Oklahoma City OK, Springfield MO, Overland Park KS,
Sponsor: Melanoma and Skin Cancer Trials Limited

Sex: All

Age: 18+

Code: NCT03860883

Recruiting

A Study to Understand How the Study Medicine (PF-06823859) Works in People With Active Idiopathic Inflammatory Myopathies [Dermatomyositis (DM) and Polymyositis (PM)]

for
Myositis
Location: Oklahoma City OK, Frisco TX, Katy TX, Houston TX,
Sponsor: Pfizer

Sex: All

Age: 18+

Code: NCT05895786

Phase 3, Recruiting

A Phase 2a/b Study to Assess the Efficacy, Safety and Tolerability of DDY391 in Participants With Sjögren's Disease

for
Sjögren's Disease
Location: Oklahoma City OK, Allen TX, Bellaire TX,
Sponsor: Novartis Pharmaceuticals

Sex: All

Age: 18 - 70+

Code: NCT07737743

Phase 2, Recruiting

Interested in new trials?

Get alerts for new trials in your area by subscribing now

Subscriber Image

Double-blind, Placebo-controlled Study in Adults With Major Depressive Disorder

for
Major Depressive Disorder (MDD)
Location: Oklahoma City OK, Wichita Falls TX, Rogers AR,
Sponsor: Supernus Pharmaceuticals, Inc.

Sex: All

Age: 18 - 70

Code: NCT07226661

Phase 2, Recruiting

Proton and Photon Consortium Registry (PPCR): A Multi Center Registry of Pediatric Patients Treated With Radiation Therapy

for
Pediatric Patients Treated With Radiation Therapy
Location: Oklahoma City OK, Irving TX, Houston TX, St Louis MO,
Sponsor: Massachusetts General Hospital

Sex: All

Age: 0 - 21

Code: NCT01696721

Recruiting

Hypo-fractionated Radiation Therapy With or Without Androgen Suppression for Intermediate Risk Prostate Cancer

for
Prostate Cancer
Location: Oklahoma City OK, Warrenville IL, Scottsdale AZ,
Sponsor: Proton Collaborative Group

Sex: Male

Age: 18+

Code: NCT01492972

Phase 3, Recruiting

Registry Study for Radiation Therapy Outcomes

for
Neoplasms
Location: Oklahoma City OK, Irving TX, Kansas City KS,
Sponsor: Proton Collaborative Group

Sex: All

Age: 0+

Code: NCT01255748

Recruiting

A Study to Assess the Efficacy, Safety, and Tolerability of IMVT-1402 as Treatment for Adult Participants With Graves' Disease

for
Graves' Disease
Location: Oklahoma City OK, McKinney TX, Irving TX, Fort Worth TX,
Sponsor: Immunovant Sciences GmbH

Sex: All

Age: 18 - 70+

Code: NCT07018323

Phase 2, Recruiting

Safety, Efficacy, and Pharmacokinetics of BNT327 in Combination With Chemotherapy and Other Investigational Agents for Lung Cancer (ROSETTA Lung-02)

for
Non-small Cell Lung Cancer
Location: Oklahoma City OK, Hastings NE, Columbia MO,
Sponsor: BioNTech SE

Sex: All

Age: 18+

Code: NCT06712316

Phase 2, Phase 3, Recruiting

A Study to Assess the Efficacy and Safety of Efgartigimod IV in Adult Participants With Primary Immune Thrombocytopenia

for
Primary Immune Thrombocytopenia (ITP)
Location: Oklahoma City OK, Aurora CO, Iowa City IA,
Sponsor: argenx

Sex: All

Age: 18+

Code: NCT06544499

Phase 3, Recruiting

Osimertinib With or Without Bevacizumab as Initial Treatment for Patients With EGFR-Mutant Lung Cancer

for
Advanced Lung Non-Squamous Non-Small Cell Carcinoma,
Location: Oklahoma City OK, Wichita KS, Richardson TX, Dallas TX,
Sponsor: National Cancer Institute (NCI)

Sex: All

Age: 18+

Code: NCT04181060

Phase 3, Recruiting

Study to Assess the Efficacy and Safety of IMVT-1402 in Participants With Mild to Severe Generalized Myasthenia Gravis

for
Generalized Myasthenia Gravis
Location: Oklahoma City OK, Yukon OK, Denton TX, Dallas TX,
Sponsor: Immunovant Sciences GmbH

Sex: All

Age: 18 - 70+

Code: NCT07039916

Phase 3, Recruiting

Study of ITI-1284 as Monotherapy Treatment in Patients With Generalized Anxiety Disorder

for
Generalized Anxiety Disorder
Location: Norman OK, Rogers AR, Dallas TX, Little Rock AR,
Sponsor: Intra-Cellular Therapies, Inc.

Sex: All

Age: 18+

Code: NCT06701903

Phase 2, Recruiting

Safety and Tolerability Trial of Lumateperone in Pediatric Patients With Schizophrenia, Bipolar Disorder or Autism Spectrum Disorder

for
Schizophrenia, Bipolar Disorder, Autism Spectrum Disorder
Location: Norman OK, Plano TX, Coppell TX, Fort Worth TX,
Sponsor: Intra-Cellular Therapies, Inc.

Sex: All

Age: 5 - 17

Code: NCT06229210

Phase 3, Recruiting

Multicenter Study of Lumateperone for the Treatment of Irritability Associated With Autism Spectrum Disorder (ASD) in Pediatric Patients

for
Irritability Associated With Autism Spectrum Disorder
Location: Norman OK, Oklahoma City OK, Coppell TX, Fort Worth TX,
Sponsor: Intra-Cellular Therapies, Inc.

Sex: All

Age: 5 - 17

Code: NCT06706674

Phase 3, Recruiting

A Trial of the Efficacy and Safety of Fixed Doses of SEP-363856 in Adults With Generalized Anxiety Disorder

for
Generalized Anxiety Disorder
Location: Oklahoma City OK, Dallas TX, DeSoto TX, New Orleans LA,
Sponsor: Otsuka Pharmaceutical Development & Commercialization, Inc.

Sex: All

Age: 18+

Code: NCT07759128

Phase 3, Recruiting

Study of ITI-1284 as an Adjunctive Treatment in Patients With Generalized Anxiety Disorder

for
Generalized Anxiety Disorder
Location: Oklahoma City OK, Plano TX, Austin TX, Atlanta GA,
Sponsor: Intra-Cellular Therapies, Inc.

Sex: All

Age: 0+

Code: NCT06480383

Phase 2, Recruiting

A Study to Assess Change in Disease Activity and Adverse Events (AEs) With Cariprazine in the Treatment of Depressive Episodes in Pediatric Participants Participants (10 to 17 Years of Age) With Bipolar I Disorder.

for
Depression, Bipolar I Disorder
Location: Oklahoma City OK, Plano TX, Coppell TX, Dallas TX,
Sponsor: AbbVie

Sex: All

Age: 10 - 17

Code: NCT04777357

Phase 3, Recruiting